Presence & RecognitionEvent: September 8, 2026
OrisDX is participating in Dentech at The ADA Forsyth Institute later this month.
Published
Signal category
Presence & Recognition
Quote
“We are thrilled to be participating in Dentech at The ADA Forsyth Institute later this month!”
— OrisDX team
Company
OrisDX
Unlocking tumor genomics in saliva to detect and diagnose cancer.
- Industry
- Biotechnology
- Location
- Chicago, US
- Company size
- 10 employees
Founded in research from the University of Chicago, OrisDX has developed a novel non-invasive salivary diagnostic test utilizing biomarker-based molecular genomic techniques to diagnose oral cavity cancers earlier.